Seeking a better tomorrow for those living with muscular dystrophy today.
Effective Treatments Powered by Science.
We are leading a crusade to reclaim lives lost to muscle-wasting diseases, driven by the belief that no one should be left behind due to biology, delayed diagnosis, or limited access to care.
Powering Discovery Through Partnerships
Our Mission
A Future Without Limits
We are transforming the treatment landscape for rare muscle diseases and significantly improving quality of life for patients and families.
Our Science
Industry-Leading Science for Muscle Regeneration
By strategically targeting α7β1 integrin and laminin, we aim to enhance muscle regeneration, promote resilience, and facilitate optimal muscle repair.
Extracellular Matrix (ECM)
The ECM supports muscle cell growth, migration, and differentiation, with α7β1 integrin linking myocytes to laminin.
Laminin
Laminin is a major component of the ECM and plays an important role in muscle development and disease.
α7β1 Integrin
α7β1 integrin connects muscle cells to the ECM, ensuring stability, providing support, growth, and development via laminin.
S-969
S-969 enhances α7 integrin expression, aiding muscle regeneration in aging, chemotherapy, and muscular diseases.
Sunitinib
Sunitinib, an FDA-approved drug, enhances α7 integrin, promoting muscle repair by activating satellite cells.
LAM 111
LAM-111 is a potential therapy for LAMA2-RD, replacing defective laminin to support muscle function.
Our Platform & Pipeline
Progress Toward In-Human Trials
SarcoScreen™ is Sarcomatrix’s proprietary high-throughput screening platform, rapidly identifying and advancing innovative muscle-targeted therapies, driving accelerated innovation, diversified risk, and enabling valuable industry partnerships.
Patient Focus
How We’re Making a Difference
We are deeply committed to actively partnering and continuously collaborating with patient advocacy groups, individuals, and families throughout every stage of their journey.
Research & Innovation
Pushing the boundaries of science to develop life-changing treatments.
Patient Care & Support
Enhancing patient well-being through dedicated care and resources.
Community & Advocacy
Championing awareness, support, and policy advancements for impact.
Our Technology
Innovative Technology Driving Muscle Regeneration
Our advanced research in extracellular matrix biology and integrin signaling is paving the way for innovative treatments that restore strength and improve lives.
S-969
Novel Target
LAM 111
News
Transforming Lives Through Muscle Science
Client Testimonials
A Whole Lot of Love From our Customers.
We endeavor to changes the lives of families and individuals living with muscular dystrophy. It’s why we raise every morning willing to tear down obstacles standing in the way of developing our breakthrough therapies.
Our team is dedicated to working with families to accelerate the drug development process and make a difference. Every day matters.
– David Craig (CEO)
Don’t be afraid of the space between your dreams and reality. If you can dream it,
you can make it so.
– Belva Davis
I’m not surprised my younger brother started a biotech company, but I am surprised and pleased that he is developing drugs that may help my husband and daughter. For all those of us living with CMD, good luck David.
– Julie Craig Nicol
